Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F D Goebel

Showing results (41-50 of 239) with videos related to

Pageof 24
Sort By:
Infection|August 11, 2005
HIV genetic diversity: any implications for drug resistance?B Jülg, F D Goebel
Infection|November 1, 2005
What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy?B Jülg, F D Goebel
Klinische Wochenschrift|September 1, 1987
[Secondary gout and pseudo-Bartter syndrome in females with laxative abuse]O Adam, F D Goebel
Infection|November 1, 2005
What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect?B Jülg, F D Goebel
Deutsche Medizinische Wochenschrift (1946)|July 21, 2000
[Metabolic complications of antiretroviral therapy of HIV infection]F D Goebel, R Walli
European Journal of Medical Research|December 28, 1999
Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, PortugalF D Goebel, H Jablonowski
Der Internist|January 17, 2002
[Risk of viral infections in colonoscopy and endoscopic procedures]R Draenert, F D Goebel
MMW Fortschritte Der Medizin|June 5, 2002
[Disorders of lipid and glucose metabolism. Long-term adverse effects of antiretroviral therapy]N Landauer, F D Goebel
Infection|August 5, 2004
What's new in HIV/AIDS. Protective immunity in HIV infection: where do we stand?R Draenert, F-D Goebel
Der Internist|February 18, 1998
[Combination treatment of HIV infection]F D Goebel, J R Bogner
Pageof 24

Showing results (41-50 of 239) with videos related to

Sort By:
Pageof 24
Infection|August 11, 2005
HIV genetic diversity: any implications for drug resistance?B Jülg, F D Goebel
Infection|November 1, 2005
What's New in HIV/AIDS? Chemokine receptor antagonists: a new era of HIV therapy?B Jülg, F D Goebel
Klinische Wochenschrift|September 1, 1987
[Secondary gout and pseudo-Bartter syndrome in females with laxative abuse]O Adam, F D Goebel
Infection|November 1, 2005
What's new in HIV/AIDS? Neutralizing HIV antibodies: do they really protect?B Jülg, F D Goebel
Deutsche Medizinische Wochenschrift (1946)|July 21, 2000
[Metabolic complications of antiretroviral therapy of HIV infection]F D Goebel, R Walli
European Journal of Medical Research|December 28, 1999
Therapy of special HIV-associated diseases: HCV-HIV-co-infection and AIDS-related Kaposi's sarcoma - official satellite to the 7th European Conference on Clinical Aspects and Treatment of HIV-infection, October 23, 1999 in Lisbon, PortugalF D Goebel, H Jablonowski
Der Internist|January 17, 2002
[Risk of viral infections in colonoscopy and endoscopic procedures]R Draenert, F D Goebel
MMW Fortschritte Der Medizin|June 5, 2002
[Disorders of lipid and glucose metabolism. Long-term adverse effects of antiretroviral therapy]N Landauer, F D Goebel
Infection|August 5, 2004
What's new in HIV/AIDS. Protective immunity in HIV infection: where do we stand?R Draenert, F-D Goebel
Der Internist|February 18, 1998
[Combination treatment of HIV infection]F D Goebel, J R Bogner
Pageof 24